medigraphic.com
ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)

2015, Number 3

<< Back Next >>

Evid Med Invest Salud 2015; 8 (3)

Breast cancer: expectations for defining its control

Guerrero-Ramos MÁ, Farías-Serratos F, Maldonado-Vega M

Language: Spanish
References: 10
Page: 122-127
PDF size: 293.81 Kb.


ABSTRACT

Cancer is a disease in which genes, proteins, enzymes and signaling molecules are involved in cell replication. This review discusses some aspects of breast cancer, with emphasis on ductal carcinoma in situ as it is the highest in frequency in the population of the world and in Mexico. This cancer increases the risk of contralateral invasive cancer and mastectomies four to five times. Another positive predictor is BRCA mutation in the development of breast cancer and first-degree relation to ovarian cancer (p ‹ 0.0278) and mastectomies (p ‹ 0.0001). Contralateral prophylactic mastectomy is a clinical strategy in the control of breast cancer, in association with hormone therapy, chemotherapy and radiotherapy. Although breast cancer can occur at younger ages and in the last stage of life, the age group with the highest incidence is between 40 and 60 years old.


REFERENCES

  1. Elsayegh N, Profato J, Barrera AM, Lin H, Kuerer HM, Ardic C et al. Predictors that influence election of contralateral prophylactic mastectomy among women with ductal carcinoma in situ who are BRCA-negative. J Cancer. 2015; 6 (7): 610-615. doi: 10.7150/jca.11710.

  2. Minami Y, Ohuchi N, Taeda Y, Fukao A, Hisamichi S. Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer. J Cancer Res. 1998; 89: 116-123.

  3. Hirose K, Hamajima N, Takezaki T, Miura S, Tajima K. Physical exercise reduces risk of breast cancer in Japanese women. Cancer Sci. 2003; 94: 193-199.

  4. Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE. Physical activity and breast cancer risk in women aged 20-54 years. J Natl Cancer Inst. 200; 92: 128-135.

  5. Goto N, Hiyoshi H, Ito I, Tsuchiya M, Nakajima Y, Yanagisawa J. Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway. Cancer Sci. 2011; 102: 1501-1508.

  6. Hamashima C, Ohta K, Kasahara Y, Katayama T, Nakayama T, Honjo S et al. A meta-analysis of mammographic screening with and without clinical breast examination. Cancer Sci. 2015; 106: 812-818.

  7. Lehmann U. Lobular breast cancer –the most common special subtype or a most special common subtype? Breast Cancer Res. 2015; 17: 99. doi: 10.1186/s13058-015-0606-z.

  8. Christgen M, Christgen H, Heil C, Krech T, Länger F, Kreipe H et al. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer. Cancer Sci. 2009; 100: 1767-1771.

  9. Zarogoulidis P, Tsakiridis K, Karapantzou C, Lampaki S, Kioumis I, Pitsiou G et al. Use of proteins as biomarkers and their role in carcinogenesis. J Cancer. 2015; 6 (1): 9-18. doi: 10.7150.jca.10560.

  10. Cuenca P, Ramírez V. Aberraciones cromosómicas en trabajadoras expuestas a plaguicidas. Rev Biol Trop. 2004; 52 (3): 623-628.




2020     |     www.medigraphic.com